About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials in Boston | 355 Studies

Clinical Trials MelanomaBoston

Melanoma Clinical Trials in Boston

Find 355 clinical trials for melanoma near Boston, Massachusetts. Connect with research centers in your area.

All Melanoma trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 355 trials

UnknownBoron Neutron Capture Therapy in Treating Patients With Stage III MelanomaRATIONALE: Boron neutron capture therapy may selectively kill tumor cells without harming normal tissue.NCT00002781·Boston, Massachusetts and 1 other CompletedVideo Education With Result Dependent dIsclosureThe overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI)…NCT05225428·Boston, Massachusetts TerminatedA Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic MelanomaTo evaluate the antitumor activity of IPI-504 in patients with metastatic melanoma.NCT00627419·Tuscon, Arizona and 16 others

Melanoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedA FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain InvolvementFirst-in-human study to assess safety, tolerability, PK, and preliminary activity of PF-07284890 as a single agent and in combination with binimetinib in participants with BRAF…NCT04543188·Duarte, California and 44 others

Active not recruitingAbbreviated MAPK Targeted Therapy Plus Pembrolizumab in MelanomaThis research study is studying a combination of drugs as a possible treatment for unresectable or metastatic melanoma.NCT03149029·Boston, Massachusetts and 2 others

UnknownVaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV MelanomaRATIONALE: Vaccines may make the body build an immune response to kill tumor cells.NCT00010309·Boston, Massachusetts and 2 others

TerminatedA Study of Volociximab in Metastatic MelanomaThis is a Phase 2, multicenter, research study determining the effects of an investigational drug called volociximab in metastatic melanoma.NCT00369395·Scottsdale, Arizona and 6 others

TerminatedTissue Procurement Substudy for Participants in Study CP-MGA271-01The purpose of this study is to gain a better understanding about how the study drug MGA271 works. No test drug will be given in this study.NCT01918930·Los Angeles, California and 6 others

Active not recruitingVeliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney DysfunctionThis phase I trial studies the side effects and the best dose of veliparib when given together with paclitaxel and carboplatin in treating patients with solid tumors that are…NCT01366144·Duarte, California and 16 others

Active not recruitingTipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment TrialThis phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have recurred or spread to other places in the body (advanced)…NCT04284774·Birmingham, Alabama and 171 others

CompletedA Study of IMM-6-415 in RAS/RAF Mutant Solid TumorsThis is a FIH, ascending dose study to characterize the safety, tolerability, optimal dose and preliminary anti-tumor activity of IMM-6-415 in participants with advanced or…NCT06208124·Scottsdale, Arizona and 4 others

CompletedUtility of Novel BRAF Test for MelanomaThis primary purpose of this study is to obtain blood samples from participants with both early and later stages of melanoma (Stage II/III and Stage IV).NCT01840527·Boston, Massachusetts and 2 others

CompletedStudy of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable MelanomaThis is an open-label, multi-center, dose-finding Phase 1 study that will enroll subjects at least 18 years old with unresectable or metastatic melanoma and BRAF V600 mutations.NCT01767454·Los Angeles, California and 6 others

Active not recruitingA Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination ImmunotherapyThis study will help determine whether 2 doses of the combination (ipilimumab + nivolumab) is sufficient for patients with early benefit compared to the usual way of trying to…NCT03122522·Hartford, Connecticut and 12 others

Active not recruitingNeoVax + CDX-301 and Nivolumab or Pembrolizumab in MelanomaThis research study is studying the drugs called NeoVax (a new type of personalized neoantigen vaccine) in combination with CDX-301 and Nivolumab or Pembrolizumab as a possible…NCT04930783·Boston, Massachusetts

CompletedMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerRATIONALE: Massage therapy may help relieve symptoms associated with cancer.NCT00253708·Boston, Massachusetts

TerminatedDinaciclib in Treating Patients With Stage III-IV MelanomaThis is a phase I/II trial is studying the side effects and best dose of dinaciclib and to see how well it works in treating patients with advanced melanoma.NCT01026324·Boston, Massachusetts

Active not recruitingA Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsThe purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) alone or in combination as a potential cancer treatment for adults with…NCT05538130·Birmingham, Alabama and 65 others

CompletedStudy of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic MelanomaThe primary purpose of this study is to evaluate the efficacy of novel spartalizumab (PDR001) combinations in previously treated unresectable or metastatic melanomaNCT03484923·Los Angeles, California and 29 others

Active not recruitingA Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07799933) administered as a single agent and in combination with other…NCT05355701·Fayetteville, Arkansas and 39 others

PreviousPage 3 of 18Next

Other Conditions in Boston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Leukemia Lymphoma